1. Home
  2. MOGO vs RLYB Comparison

MOGO vs RLYB Comparison

Compare MOGO & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mogo Inc.

MOGO

Mogo Inc.

HOLD

Current Price

$1.30

Market Cap

29.0M

Sector

N/A

ML Signal

HOLD

Logo Rallybio Corporation

RLYB

Rallybio Corporation

HOLD

Current Price

$0.66

Market Cap

24.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGO
RLYB
Founded
2003
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.0M
24.1M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MOGO
RLYB
Price
$1.30
$0.66
Analyst Decision
Strong Buy
Hold
Analyst Count
1
2
Target Price
$4.00
N/A
AVG Volume (30 Days)
145.9K
229.6K
Earning Date
11-07-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$29,215,516.00
$674,000.00
Revenue This Year
$61.97
N/A
Revenue Next Year
$6.28
N/A
P/E Ratio
$5.66
N/A
Revenue Growth
N/A
12.71
52 Week Low
$0.74
$0.22
52 Week High
$3.83
$1.24

Technical Indicators

Market Signals
Indicator
MOGO
RLYB
Relative Strength Index (RSI) 41.09 55.02
Support Level $1.11 $0.59
Resistance Level $1.26 $0.68
Average True Range (ATR) 0.08 0.05
MACD 0.02 -0.00
Stochastic Oscillator 64.52 46.34

Price Performance

Historical Comparison
MOGO
RLYB

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: